Total Payments
$2,587
2023 Payments
$543.70
Companies
24
Transactions
114
Medicare Patients
208
Medicare Billing
$57,709
Payment Breakdown by Category
Food & Beverage$2,499 (96.6%)
Education$88.44 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,499 | 110 | 96.6% |
| Education | $88.44 | 4 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $434.91 | 10 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $389.74 | 5 | $0 (2021) |
| Allergan, Inc. | $241.87 | 13 | $0 (2020) |
| ABBVIE INC. | $234.48 | 12 | $0 (2023) |
| Merck Sharp & Dohme LLC | $197.71 | 12 | $0 (2022) |
| Lundbeck LLC | $140.95 | 7 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $138.33 | 15 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $122.98 | 7 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $94.12 | 4 | $0 (2017) |
| ITI, Inc. | $83.88 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $543.70 | 13 | Teva Pharmaceuticals USA, Inc. ($382.48) |
| 2022 | $251.45 | 13 | ABBVIE INC. ($70.21) |
| 2021 | $401.47 | 15 | Neurocrine Biosciences, Inc. ($128.61) |
| 2020 | $53.41 | 4 | Sunovion Pharmaceuticals Inc. ($42.16) |
| 2019 | $402.96 | 12 | Neurocrine Biosciences, Inc. ($246.36) |
| 2018 | $438.49 | 28 | Allergan Inc. ($88.37) |
| 2017 | $496.00 | 29 | Allergan Inc. ($142.25) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Neurology | ||||||
| 11/16/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $108.46 | General |
| Category: Neurology | ||||||
| 11/03/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Neurology | ||||||
| 09/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/05/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $45.39 | General |
| Category: Neurology | ||||||
| 05/24/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: Central Nervous System | ||||||
| 04/20/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $126.22 | General |
| Category: Central Nervous System | ||||||
| 04/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: INSOMNIA | ||||||
| 03/22/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $43.76 | General |
| Category: Central Nervous System | ||||||
| 03/04/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/01/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $26.41 | General |
| Category: PSYCHOLOGY | ||||||
| 01/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: INSOMNIA | ||||||
| 10/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Central Nervous System | ||||||
| 08/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $4.78 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/01/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/01/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 07/13/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.86 | General |
| 06/08/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: PSYCHIATRY | ||||||
| 04/12/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/18/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 41 | $19,615 | $2,312 |
| 2022 | 2 | 43 | 121 | $28,742 | $8,243 |
| 2021 | 5 | 91 | 344 | $50,300 | $28,462 |
| 2020 | 3 | 56 | 231 | $33,670 | $18,691 |
Total Patients
208
Total Services
737
Medicare Billing
$57,709
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 41 | $19,615 | $2,312 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 107 | $24,578 | $6,045 | 24.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 14 | $4,164 | $2,197 | 52.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 181 | $27,150 | $15,151 | 55.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 118 | $12,980 | $7,833 | 60.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 14 | 14 | $3,640 | $2,025 | 55.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $3,640 | $1,928 | 53.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 17 | 17 | $2,890 | $1,525 | 52.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 139 | $20,850 | $12,200 | 58.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 74 | $8,140 | $3,427 | 42.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 18 | $4,680 | $3,064 | 65.5% |
About Dr. Jonathan Koelle, MD
Dr. Jonathan Koelle, MD is a Psychiatry healthcare provider based in La Mesa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609803824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Koelle, MD has received a total of $2,587 in payments from pharmaceutical and medical device companies, with $543.70 received in 2023. These payments were reported across 114 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,499).
As a Medicare-enrolled provider, Koelle has provided services to 208 Medicare beneficiaries, totaling 737 services with total Medicare billing of $57,709. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location La Mesa, CA
- Active Since 06/26/2006
- Last Updated 02/21/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1609803824
Products in Payments
- VRAYLAR (Drug) $446.49
- INGREZZA (Drug) $389.74
- Trintellix (Drug) $217.10
- BELSOMRA (Drug) $197.71
- AUSTEDO (Drug) $184.07
- UZEDY (Drug) $178.13
- LATUDA (Drug) $138.33
- REXULTI (Drug) $116.38
- CAPLYTA (Drug) $83.88
- Azstarys (Drug) $63.66
- HETLIOZ (Drug) $49.72
- NEUROSTAR TMS THERAPY SYSTEM (Device) $48.80
- TRINTELLIX (Drug) $44.49
- SD809-TD (Drug) $38.34
- QUVIVIQ (Drug) $37.75
- METHYLPHENIDATE 72 (Drug) $37.40
- INVEGA SUSTENNA (Drug) $36.40
- Austedo XR (Drug) $34.37
- ABILIFY MAINTENA (Drug) $33.35
- NeuroStar TMS Therapy (Device) $32.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in La Mesa
Brian Miller, M.d, M.D
Psychiatry — Payments: $132,703
Psychiatry $132,703
Samuel Etchie, M.d, M.D
Psychiatry — Payments: $73,511
Psychiatry $73,511
Mrs. Nita Paintal, Md, MD
Psychiatry — Payments: $5,451
Psychiatry $5,451
Dr. Jon Highum, M.d, M.D
Psychiatry — Payments: $1,911
Psychiatry $1,911
Sanjay Rao, M.d, M.D
Psychiatry — Payments: $1,638
Psychiatry $1,638
Dr. Vladimir Khalafian, M.d, M.D
Psychiatry — Payments: $612.66
Psychiatry $612.66